194 related articles for article (PubMed ID: 34184341)
21. Distant metastatic potential in primary renal sarcoma with MEIS1-NCOA2 gene fusion.
Quiroga-Garza GM; Lajara S; Burgess MA; John I
Histopathology; 2021 Jul; 79(1):117-118. PubMed ID: 33527513
[No Abstract] [Full Text] [Related]
22. Rhabdomyosarcoma With
Zhong P; Wei S; Xiao H; Zeng Y
Int J Surg Pathol; 2024 Jun; 32(4):758-766. PubMed ID: 37545350
[TBL] [Abstract][Full Text] [Related]
23. Recurrent VGLL3 fusions define a distinctive subset of spindle cell rhabdomyosarcoma with an indolent clinical course and striking predilection for the head and neck.
Agaimy A; Dermawan JK; Leong I; Stoehr R; Swanson D; Weinreb I; Zhang L; Antonescu CR; Dickson BC
Genes Chromosomes Cancer; 2022 Dec; 61(12):701-709. PubMed ID: 35766997
[TBL] [Abstract][Full Text] [Related]
24. Low-grade undifferentiated sarcoma with MEIS1::NCOA2-rearrangement primary to the lung: a case report.
Coty-Fattal Z; Carter B; Volek MJ; Obeidin F
Diagn Pathol; 2024 Apr; 19(1):65. PubMed ID: 38678288
[TBL] [Abstract][Full Text] [Related]
25. Intraosseous Spindle Cell/Epithelioid Rhabdomyosarcoma with
Valério E; Furtado Costa JL; Perez Fraile NM; Credidio CH; Taveira Garcia MR; Neto CS; Costa FD
Int J Surg Pathol; 2023 Aug; 31(5):861-865. PubMed ID: 36474403
[TBL] [Abstract][Full Text] [Related]
26. Novel EWSR1::UBP1 fusion expands the spectrum of spindle cell rhabdomyosarcomas.
El Zein S; Djeroudi L; Reynaud S; Guillemot D; Masliah-Planchon J; Frouin E; Nicolas N; Le Loarer F; Daniel C; Delattre O; Pierron G; Watson S
Genes Chromosomes Cancer; 2022 Apr; 61(4):200-205. PubMed ID: 34877752
[TBL] [Abstract][Full Text] [Related]
27. VGLL2-NCOA2 leverages developmental programs for pediatric sarcomagenesis.
Watson S; LaVigne CA; Xu L; Surdez D; Cyrta J; Calderon D; Cannon MV; Kent MR; Silvius KM; Kucinski JP; Harrison EN; Murchison W; Rakheja D; Tirode F; Delattre O; Amatruda JF; Kendall GC
Cell Rep; 2023 Jan; 42(1):112013. PubMed ID: 36656711
[TBL] [Abstract][Full Text] [Related]
28. Aggressive High-grade Uterine Sarcoma Harboring MEIS1-NCOA2 Fusion and Amplification of Multiple 12q13-15 Genes: A Case Report With Morphologic, Immunohistochemical, and Molecular Analysis.
Niu S; Rivera-Colon G; Lucas E
Int J Gynecol Pathol; 2023 Sep; 42(5):460-465. PubMed ID: 36811835
[TBL] [Abstract][Full Text] [Related]
29. The current landscape of rhabdomyosarcomas: an update.
Leiner J; Le Loarer F
Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
[TBL] [Abstract][Full Text] [Related]
30. MYOD1-mutant spindle cell and sclerosing rhabdomyosarcoma: an aggressive subtype irrespective of age. A reappraisal for molecular classification and risk stratification.
Agaram NP; LaQuaglia MP; Alaggio R; Zhang L; Fujisawa Y; Ladanyi M; Wexler LH; Antonescu CR
Mod Pathol; 2019 Jan; 32(1):27-36. PubMed ID: 30181563
[TBL] [Abstract][Full Text] [Related]
31. Pediatric spindle cell/sclerosing rhabdomyosarcoma with
Fang Z; Duan C; Wang S; Fu L; Yang P; Yu T; Deel MD; Lau LMS; Ma X; Ni X; Su Y
Transl Pediatr; 2024 Jan; 13(1):178-191. PubMed ID: 38323177
[TBL] [Abstract][Full Text] [Related]
32. The expanding morphological and genetic spectrum of MYOD1-mutant spindle cell/sclerosing rhabdomyosarcomas: a clinicopathological and molecular comparison of mutated and non-mutated cases.
Tsai JW; ChangChien YC; Lee JC; Kao YC; Li WS; Liang CW; Liao IC; Chang YM; Wang JC; Tsao CF; Yu SC; Huang HY
Histopathology; 2019 May; 74(6):933-943. PubMed ID: 30604891
[TBL] [Abstract][Full Text] [Related]
33. Sclerosing rhabdomyosarcoma in adults: report of four cases of a hyalinizing, matrix-rich variant of rhabdomyosarcoma that may be confused with osteosarcoma, chondrosarcoma, or angiosarcoma.
Folpe AL; McKenney JK; Bridge JA; Weiss SW
Am J Surg Pathol; 2002 Sep; 26(9):1175-83. PubMed ID: 12218574
[TBL] [Abstract][Full Text] [Related]
34. Molecular diagnostics in the management of rhabdomyosarcoma.
Arnold MA; Barr FG
Expert Rev Mol Diagn; 2017 Feb; 17(2):189-194. PubMed ID: 28058850
[TBL] [Abstract][Full Text] [Related]
35. Histopathological, immunohistochemical and molecular cytogenetic analysis of 21 spindle cell/sclerosing rhabdomyosarcomas.
Rekhi B; Singhvi T
APMIS; 2014 Nov; 122(11):1144-52. PubMed ID: 24730567
[TBL] [Abstract][Full Text] [Related]
36. Integrative clinical and biopathology analyses to understand the clinical heterogeneity of infantile rhabdomyosarcoma: A report from the French MMT committee.
Butel T; Karanian M; Pierron G; Orbach D; Ranchere D; Cozic N; Galmiche L; Coulomb A; Corradini N; Lacour B; Proust S; Guerin F; Boutroux H; Rome A; Mansuy L; Vérité C; Defachelles AS; Tirode F; Minard-Colin V
Cancer Med; 2020 Apr; 9(8):2698-2709. PubMed ID: 32087612
[TBL] [Abstract][Full Text] [Related]
37. Clinicopathological and Molecular Characteristics of Intraosseous Rhabdomyosarcoma Involving Head and Neck Region: A Systematic Review and Meta-Analysis.
Sivakumar N; Sharma P; Chandra S; Gupta S; Samadi FM; Baghel S
Pediatr Dev Pathol; 2023; 26(3):299-309. PubMed ID: 37082926
[TBL] [Abstract][Full Text] [Related]
38. Challenges in the Diagnosis of Pediatric Spindle Cell/Sclerosing Rhabdomyosarcoma.
Chen S; Rudzinski ER; Arnold MA
Surg Pathol Clin; 2020 Dec; 13(4):729-738. PubMed ID: 33183730
[TBL] [Abstract][Full Text] [Related]
39. Congenital spindle cell rhabdomyosarcoma: An international cooperative analysis.
Whittle S; Venkatramani R; Schönstein A; Pack SD; Alaggio R; Vokuhl C; Rudzinski ER; Wulf AL; Zin A; Gruver JR; Arnold MA; Merks JHM; Hettmer S; Koscielniak E; Barr FG; Hawkins DS; Bisogno G; Sparber-Sauer M
Eur J Cancer; 2022 Jun; 168():56-64. PubMed ID: 35452896
[TBL] [Abstract][Full Text] [Related]
40. Transactivating mutation of the MYOD1 gene is a frequent event in adult spindle cell rhabdomyosarcoma.
Szuhai K; de Jong D; Leung WY; Fletcher CD; Hogendoorn PC
J Pathol; 2014 Feb; 232(3):300-7. PubMed ID: 24272621
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
